Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Automated MRI features of MS and common radiological mimickers
Multiple Sclerosis
P15 - Poster Session 15 (5:30 PM-6:30 PM)
12-008

The diagnosis of MS relies on exclusion of alternate neurological disorders. Misdiagnosis of MS is mainly due to improper interpretation of MRI and distinguishing MS from radiological mimics can be challenging.

To evaluate radiological features to optimally distinguish multiple sclerosis (MS) from other disorders with white matter lesions.

Patients with standardized MRI acquired on 3T Siemens scanners across the health care system were included and classified, based on clinical chart review as MS (final diagnosis of MS) and non-MS cohorts (final diagnosis non-specific changes, migraine related changes, small vessel disease ischemic changes, and other diagnoses). The earliest available MRIs within the first 5 years of disease onset were included for MS patients. Variables included lesion volumes, whole brain, and regional volumes. Variables with greater than 80% correlation with other variables were removed. A logistic regression model with Ridge regularization and grid-search was applied to the cohort to select the top 6 features distinguishing MS from other disease states.

The MS cohort included 665 patients: 210 (32%) male, 532 (80%) Caucasian, and 89 (13%) African American. The non-MS cohort included 501 patients: 102 (20%) male, 395 (79%) Caucasian, and 44 (9%) African American. In the MS cohort, the average disease duration was 2.9 ± 1.4 years, the average age at time of MRI scan was 40.5 ± 11.7, and the average age at MS diagnosis was 36.6 ± 11.1 years. The top 6 variables included T2 lesion volume and thalamic sub-regional volumes and the logistic regression model was able to predict MS with an accuracy of 63% and AUC of 71%.

In addition to traditional criteria, MRI features captured using automated methods assessing lesion pathology and selective degeneration could be used to differentiate MS from mimickers. 
Authors/Disclosures
Moein Amin, MD (Cleveland Clinic)
PRESENTER
Dr. Amin has nothing to disclose.
Kunio Nakamura, PhD (Cleveland Clinic) Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Daniel Ontaneda, MD, PhD, FAAN (Cleveland Clinic) Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.